Lutetium, actinium and the next isotope race: inside radiopharmaceutical cancer therapy
Radiotheranostics pairs molecular imaging with targeted radioactive drugs, allowing clinicians to confirm whether a tumor carries the therapeutic target before delivering radiation systemically.